APA (7th ed.) Citation

Dijkstra, J., van Altena, R., Akkerman, O., de Lange, W., Proost, J., van der Werf, T., . . . Alffenaar, J. (2015). Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis. International journal of antimicrobial agents, 46(3), 332-337. https://doi.org/10.1016/j.ijantimicag.2015.06.008

Chicago Style (17th ed.) Citation

Dijkstra, J.A, R. van Altena, O.W Akkerman, W.C.M de Lange, J.H Proost, T.S van der Werf, J.G.W Kosterink, and J.W.C Alffenaar. "Limited Sampling Strategies for Therapeutic Drug Monitoring of Amikacin and Kanamycin in Patients with Multidrug-resistant Tuberculosis." International Journal of Antimicrobial Agents 46, no. 3 (2015): 332-337. https://doi.org/10.1016/j.ijantimicag.2015.06.008.

MLA (9th ed.) Citation

Dijkstra, J.A, et al. "Limited Sampling Strategies for Therapeutic Drug Monitoring of Amikacin and Kanamycin in Patients with Multidrug-resistant Tuberculosis." International Journal of Antimicrobial Agents, vol. 46, no. 3, 2015, pp. 332-337, https://doi.org/10.1016/j.ijantimicag.2015.06.008.